NO20024351D0 - Nye 1-[1-(hetero)aryl-1-perhydroksyalkylmetyl]- piperazinforbindelser, fremgangsmåte for deres fremstilling oglegemiddel som inneholder disse forbindelsene - Google Patents
Nye 1-[1-(hetero)aryl-1-perhydroksyalkylmetyl]- piperazinforbindelser, fremgangsmåte for deres fremstilling oglegemiddel som inneholder disse forbindelseneInfo
- Publication number
- NO20024351D0 NO20024351D0 NO20024351A NO20024351A NO20024351D0 NO 20024351 D0 NO20024351 D0 NO 20024351D0 NO 20024351 A NO20024351 A NO 20024351A NO 20024351 A NO20024351 A NO 20024351A NO 20024351 D0 NO20024351 D0 NO 20024351D0
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- perhydroxyalkylmethyl
- hetero
- aryl
- preparation
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 125000005842 heteroatom Chemical group 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10145044A DE10145044A1 (de) | 2001-09-13 | 2001-09-13 | Neue 1-[1-(Hetero)aryl-1-perhydroxyalkylmethyl]-Piperazinverbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20024351D0 true NO20024351D0 (no) | 2002-09-12 |
NO20024351L NO20024351L (no) | 2003-03-14 |
NO324867B1 NO324867B1 (no) | 2007-12-17 |
Family
ID=7698848
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20024351A NO324867B1 (no) | 2001-09-13 | 2002-09-12 | Nye 1-[1-(hetero)aryl-1-perhydroksyalkylmetyl]-piperazinforbindelser, fremgangsmate for deres fremstilling, legemidler som inneholder disse forbindelsene, anvendelse av forbindelsene til fremstilling av farmasoytiske preparater, samt mellomprodukter i fremgangsmaten |
Country Status (27)
Country | Link |
---|---|
US (1) | US6770649B2 (no) |
EP (1) | EP1293506B1 (no) |
JP (1) | JP4353684B2 (no) |
KR (1) | KR100909746B1 (no) |
CN (1) | CN1232513C (no) |
AR (1) | AR036487A1 (no) |
AT (1) | ATE305464T1 (no) |
AU (1) | AU2002301141B2 (no) |
BR (1) | BR0203716A (no) |
CA (1) | CA2403139C (no) |
DE (2) | DE10145044A1 (no) |
DK (1) | DK1293506T3 (no) |
DZ (1) | DZ3292A1 (no) |
ES (1) | ES2250561T3 (no) |
HK (1) | HK1053648A1 (no) |
HU (1) | HU227612B1 (no) |
IL (1) | IL151497A (no) |
MX (1) | MXPA02008789A (no) |
NO (1) | NO324867B1 (no) |
NZ (1) | NZ521154A (no) |
PL (1) | PL356018A1 (no) |
PT (1) | PT1293506E (no) |
RU (1) | RU2301807C2 (no) |
SI (1) | SI1293506T1 (no) |
TW (1) | TWI254046B (no) |
UA (1) | UA75590C2 (no) |
ZA (1) | ZA200206731B (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4918031B2 (ja) * | 2005-03-31 | 2012-04-18 | 日本臓器製薬株式会社 | ベンジルオキシプロピルアミン誘導体 |
JP2009517443A (ja) * | 2005-11-30 | 2009-04-30 | ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規のnk1およびnk2拮抗薬 |
US7592344B2 (en) | 2005-11-30 | 2009-09-22 | Solvay Pharmaceuticals Gmbh | NK1 and NK2-antagonists and compositions and methods of using the same |
CN103387549A (zh) * | 2012-05-10 | 2013-11-13 | 广州医学院 | 三个苯并三氮唑类芳基哌嗪化合物的消旋体和光学异构体及其制备方法和用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE903957A1 (en) * | 1989-11-06 | 1991-05-08 | Sanofi Sa | Aromatic amine compounds, their method of preparation and¹pharmaceutical compositions in which they are present |
IL99320A (en) * | 1990-09-05 | 1995-07-31 | Sanofi Sa | Arylalkylamines, their preparation and pharmaceutical preparations containing them |
EP0709375B1 (en) * | 1994-10-25 | 2005-05-18 | AstraZeneca AB | Therapeutic heterocycles |
AU2001244999A1 (en) * | 2000-04-06 | 2001-10-23 | Astrazeneca Ab | Naphthamide neurokinin antagonists for use as medicaments |
-
2000
- 2000-09-14 DZ DZ020227A patent/DZ3292A1/fr active
-
2001
- 2001-09-13 DE DE10145044A patent/DE10145044A1/de not_active Withdrawn
-
2002
- 2002-08-15 TW TW091118380A patent/TWI254046B/zh not_active IP Right Cessation
- 2002-08-22 AR ARP020103153A patent/AR036487A1/es active IP Right Grant
- 2002-08-22 ZA ZA200206731A patent/ZA200206731B/xx unknown
- 2002-08-27 IL IL151497A patent/IL151497A/en not_active IP Right Cessation
- 2002-09-03 NZ NZ521154A patent/NZ521154A/en not_active IP Right Cessation
- 2002-09-06 KR KR1020020053771A patent/KR100909746B1/ko not_active IP Right Cessation
- 2002-09-07 PT PT02020115T patent/PT1293506E/pt unknown
- 2002-09-07 DE DE50204379T patent/DE50204379D1/de not_active Expired - Lifetime
- 2002-09-07 SI SI200230195T patent/SI1293506T1/sl unknown
- 2002-09-07 EP EP02020115A patent/EP1293506B1/de not_active Expired - Lifetime
- 2002-09-07 DK DK02020115T patent/DK1293506T3/da active
- 2002-09-07 AT AT02020115T patent/ATE305464T1/de active
- 2002-09-07 ES ES02020115T patent/ES2250561T3/es not_active Expired - Lifetime
- 2002-09-09 MX MXPA02008789A patent/MXPA02008789A/es active IP Right Grant
- 2002-09-09 HU HU0202967A patent/HU227612B1/hu not_active IP Right Cessation
- 2002-09-11 CN CNB021315566A patent/CN1232513C/zh not_active Expired - Fee Related
- 2002-09-11 UA UA2002097386A patent/UA75590C2/uk unknown
- 2002-09-11 JP JP2002265969A patent/JP4353684B2/ja not_active Expired - Fee Related
- 2002-09-12 BR BR0203716-5A patent/BR0203716A/pt not_active IP Right Cessation
- 2002-09-12 PL PL02356018A patent/PL356018A1/xx not_active Application Discontinuation
- 2002-09-12 AU AU2002301141A patent/AU2002301141B2/en not_active Ceased
- 2002-09-12 RU RU2002124199/04A patent/RU2301807C2/ru not_active IP Right Cessation
- 2002-09-12 NO NO20024351A patent/NO324867B1/no not_active IP Right Cessation
- 2002-09-13 US US10/242,678 patent/US6770649B2/en not_active Expired - Lifetime
- 2002-09-13 CA CA2403139A patent/CA2403139C/en not_active Expired - Fee Related
-
2003
- 2003-08-08 HK HK03105680A patent/HK1053648A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20032733L (no) | Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse | |
NO20054876D0 (no) | Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser | |
NO20030381D0 (no) | Bicyklopyrazoler som er aktive som kinaseinhibitorer, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder slikeforbindelser | |
EE05454B1 (et) | 1-[4-(5-tsanoindool-3-l)butl]-4-(2-karbamolbensofuraan-5-l)piperasiinvesinikkloriidi polmorfsed vormid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid | |
NO20031273D0 (no) | Substituerte kanelsyreguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som legemiddel og legemiddel som inneholder de samme | |
NO20032735L (no) | Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene samt deres anvendelse | |
NO20032726L (no) | Kinazolinderivater, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmåte for fremstilling derav | |
DK1427730T3 (da) | Nye dihydropteridinoner, fremgangsmåde til fremstilling af disse og anvendelse af disse som lægemiddel | |
DK1218341T3 (da) | Sulfonylcarboxamid-derivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel | |
DK1585743T3 (da) | 2-(H-indazol-6-ylamino)-benzamid forbindelser som protein kinase inhibitorer, nyttige til behandling opthalmiske sygdomme | |
DK1294682T3 (da) | Acylphenylurinstofderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel | |
NO20006251D0 (no) | Benzotiepin-1,1-dioksidderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse | |
NO20054220D0 (no) | Substituerte N-arylheterocykler, fremgangsmate for fremstilling derav og deres anvendelse som legemiddel | |
DK1226188T3 (da) | Fremgangsmåde til fremstilling af mannichaddukter, som indeholder polyisobutenphenol | |
BRPI0014735B1 (pt) | composto 3-z-[1-(4-(n-((4-metil-piperazin-1-il)-metilcarbonil)-n-met il-amino)-anilino)-1-fenil-metileno]-6-metóxicarbonil- 2-indolinona, seus sais e seu uso, bem como composição farmacêutica e seu processo de preparação. | |
NO20030494D0 (no) | Nye heterosykliske forbindelser, deres fremstilling og deres anvendelse sommedikamenter, s¶rlig som antibakterielle midler | |
DK1417206T3 (da) | Hidtil ukendte 2H-pyridazin-3-on-derivater, farmaceutiske præparater indeholdende det samme, og en fremgangsmåde til fremstilling af den aktive bestanddel | |
ATE482207T1 (de) | Cyclische harnstoffderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung als kinaseinhibitoren | |
DK1453810T3 (da) | Substituerede 4-phenyltetrahydroisoquinoliner, fremgangsmåde til deres fremstilling, deres anvendelse som medikament indeholdende samme | |
HUP0501016A2 (en) | (s)-4-amino-5-chloro-2-methoxy-n-{1-[1-(2-tetrahydrofurylcarbonyl)-4-piperidinylmethyl]-4-piperidinyl}benzamide, process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor | |
NO20044322L (no) | Benzoksanon-avledede forbindelser, deres fremstilling og anvendelse som medikament | |
HK1096960A1 (en) | Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h- chromium-6-yl-derivatives and drugs containing said compounds | |
NO20024351D0 (no) | Nye 1-[1-(hetero)aryl-1-perhydroksyalkylmetyl]- piperazinforbindelser, fremgangsmåte for deres fremstilling oglegemiddel som inneholder disse forbindelsene | |
DK2067779T3 (da) | Tiotropiumsalte, fremgangsmåde til deres fremstilling og lægemiddelformuleringer indeholdende disse | |
NO20035163D0 (no) | Nye piperidinkarboksamid-derivater, fremgangsmåte for deres fremstilling ogfarmasöytiske preparater inneholdende de samme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |